Explore how taletrectinib's CNS penetration may delay brain metastases and reduce the need for radiation in non–small cell lung cancer patients with ROS1.
Lyudmila Bazhenova, MD
Advertisement
Lyudmila A. Bazhenova, MD, is a medical oncologist and professor of medicine at UC San Diego Health.
Articles by Lyudmila Bazhenova, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
An Early Look at EHA 2026: 10 Key Studies Heading to Stockholm
2
Dr Hurvitz on Gedatolisib's Superior Efficacy in PIK3CA+ Breast Cancer
3
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
4
May 2026: FDA Oncology Actions at a Glance
5